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ABSTRACT
PURPOSE: To investigate the effect of sildenafil citrate (SC) on skeletal muscle ischemia-reperfusion (IR) injury in rats.
METHODS: Adult male Wistar rats were randomized into three groups: vehicle-treated control (CTG), sildenafil citrate-treated (SCG), 
and sham group (SG). CTG and SCG had femoral artery occluded for 6 hours. Saline or 1 mg/kg of SC was given 5.5 hours after 
occlusion. SG had a similar procedure without artery occlusion. Soleus muscle samples were acquired 4 or 24h after the reperfusion. 
Immunohistochemistry caspase-3 analysis was used to estimate apoptosis using the apoptotic ratio (computed as positive/negative 
cells). Wilcoxon rank-sum or Kruskal-Wallis tests were used to assess differences among groups. 
RESULTS: Eighteen animals were included in the 4h reperfusion groups and 21 animals in the 24h reperfusion groups. The mean 
apoptotic ratio was 0.18±0.1 for the total cohort; 0.14±0.06 for the 4h reperfusion groups and 0.19±0.08 for the 24h groups (p<0.05). 
The SCG had lower caspase-3 ratio compared to the control groups at the 24h reperfusion time point (p<0.05). 
CONCLUSION: Sildenafil citrate administration after the onset of the ischemic injury reduces IR-induced cellular damage in skeletal 
muscle in this rat hindlimb ischemia model.
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Introduction
Ischemia-reperfusion injury (IRI) in skeletal muscle 
has complex and multifactorial mechanisms. Reestablishment 
of blood flow is essential to salvage ischemic tissues, but may 
also lead to cellular damage beyond that caused by the initial 
ischemia. Numerous reactive oxygen species (ROS) are brought 
along when oxygenated blood flow re-enters ischemic tissues 
during reperfusion, leading to additional tissue injury. Moreover, 
inflammatory mediators are also generated, aggravating the local 
cell death1,2.  
As mechanisms of cell death, both necrosis and apoptosis 
can be induced by IRI. Necrosis used to be considered the solo 
mechanism in ischemic conditions, but current evidence show 
apoptosis as the major contributor to cell death due to IRI3,4. 
Quantifying and mapping apoptosis indicates the extension of IRI3. 
For the quantification of apoptosis, the assessment of caspase-3 
expression by immunohistochemistry staining is a validated and 
standardized method5. 
Hindlimb ischemia due to arterial occlusion is a common 
condition in clinical practice6. Skeletal muscles are the predominant 
tissue damaged in this situation, with high vulnerability to 
cell death due to ischemia. Typically, severe injury in skeletal 
musculature starts after a 2-hours ischemic interval1,7. However, 
irreversible muscle cell damage seems to start after three hours of 
ischemia and to be nearly complete after a 6- hours interval8.
Sildenafil citrate (SC) is a phosphodiesterase-5 inhibitor 
able to increase nitric oxide release, improving endothelial 
function9. Promising results have been shown for the use of SC in 
animal models of myocardial IRI, as well as inducing protective 
effects in the kidney10,11. However, the role of SC as a protective 
agent during IRI in skeletal muscles is still unknown. 
The aim of this study is to determine whether 
pharmacologic postconditioning with SC is effective to reduce IRI 
in skeletal muscle, using an experimental model of rodent limb 
ischemia.
Methods
We included 42 male Wistar albino rats in the study, but 
three were excluded after the surgical procedure due to research 
protocol violation. The animals were kept under controlled 
environmental conditions of temperature, noise, and a cycle of 
twelve hours for light and dark, with free access to water and 
adequate chow for the species.  The investigational protocol 
was approved by the Institutional Animal Care Committee, and 
the research was performed in accordance with the guidelines 
of the Brazilian legislation for scientific use of animals (Law nº 
11.794/08).
Groups and surgical procedure
The animals were randomized to one of three groups: 
1) vehicle-treated sham group (SG); 2) vehicle-treated control 
group (CTG); and 3) sildenafil citrate-treated group (SCG). The 
rats were anesthetised with ketamine hydrochloride (75mg/kg) 
and xylazine (10mg/kg) intraperitoneally and kept spontaneously 
breathing in room air. Tramadol hydrochloride (2mg/kg) IM was 
given immediately before the surgical procedure. For the SCG 
and CTG, the femoral artery was dissected and then clamped 
with a vascular microclamp just below the bifurcation of the deep 
femoral artery (Figure 1). Ischemia was confirmed by the presence 
of clinical signs of ischemia (cutaneous cyanosis and pallor, 
reduced temperature compared to the contralateral limb) as well 
as by the disappearance of arterial pulsatility distal to vascular 
clamp. In SG, a similar surgical procedure was performed without 
femoral artery occlusion. The animals were placed in individual 
cages under heat of red-hot lamps up to the recuperation of the 
anesthesia and with free access to food and water. The SCG then 
received 1mg/kg of SC in saline by gavage 5.5h after the onset 
of ischemia, while the CTG received only saline by gavage at 
5.5h. In SG, the animals received saline by gavage 5.5h after 
the surgical procedure. Six hours after clamping, the blood flow 
was re-established in the femoral artery by removing the clamp. 
The reperfusion was confirmed by the disappearance of clinical 
parameters of ischemia. The animals were placed in individual 
cages under heat during the reperfusion period. After 4h or 24h 
(according to group protocol), the soleus muscle was excised and 
euthanasia was then performed.
Tissue processing and analysis
The soleus muscle was fixed in 10% buffered formalin 
for 24 hours, dehydrated, and then embedded in paraffin. 
Sections (6 mm) of the central part of all samples were stained 
for caspase-3 expression.  The immunohistochemical processing 
was performed using the primary antibody-cleaved anticaspase-3, 
anti-mouse (DakoTM A/S, Denmark 492), revealing DAB (3, 
3-diaminobenzidine) Sigma Co-USAD5632 and obtaining the 
expression of the caspase-3 staining brown. The quantification 
of caspase-3 expression was performed in a blinded fashion. 
Ten images of each animal slide were captured, using an 
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optical microscope at 10x 40x (400x) magnification (NikonTM, 
Inc.) connected to a workstation. The apoptotic ratio (AR) was 
determined by quantifying the number of caspase-3 positive 
myocyte nuclei divided by the number of caspase-3 negative 
myocyte nuclei in each image (Figure 1). To assess reproducibility, 
a slide was randomly selected from each animal and independently 
analyzed by a second reader. 
FIGURE 1 - Vascular microclamp and surgical femoral artery occlusion. 
IL – inguinal ligament; CFA – common femoral artery; SEA – superficial 
epigastric artery; FA – femoral artery.
Statistical analysis
Statistical analysis was performed using STATA version 
11.2. Difference between groups was tested using the Wilcoxon 
rank-sum test when two groups were involved or using the 
Kruskal-Wallis test when more than two groups were examined. 
The protective effect of sildenafil citrate was assessed by 
comparing mean values of AR among groups (SG, SCG and CTG) 
in total and according to the reperfusion time. The reproducibility 
analysis was performed using intraclass correlation coefficient and 
Bland-Altman plots. The level of significance for rejecting the null 
hypothesis was 5% (p<0.05).
Results
A total of 39 animals were included, with the mean weight 
of 350 ± 20 g. Of those, 18 animals underwent 4h of reperfusion 
(six animals in each of three groups: SG, CTG and SCG) and 21 
animals underwent 24h of reperfusion (seven rats in each of three 
groups: SG, CTG and CSG). 
Figures 2, 3 and 4 show photomicrographs of the 
immunohistochemical expression characteristics of cleaved 
caspase-3 in animals from CTG, SCG and SG after 24h of 
reperfusion.
FIGURE 2 - Photomicrograph of a vehicle-treated control group (CTG) 
animal after 24 hours of reperfusion for immunohistochemical evaluation 
of caspase-3 expression in brown staining (arrows). Extensive apoptotic 
nuclei observed in 40x10 magnification. 
FIGURE 3 - Photomicrograph of a sildenafil citrate group (CSG) animal 
after 24 hours of reperfusion for immunohistochemical evaluation of 
caspase-3 expression in brown staining (arrows). Apoptotic nuclei present 
to a lesser extent (40x10 magnification).
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FIGURE 4 - Photomicrograph of an animal of vehicle-treated sham group 
(SG) after 24 hours of reperfusion for immunohistochemical evaluation of 
caspase-3 expression in brown staining (arrows). Presence of few stained 
cells in the upper left quadrant (40x10 magnification).
The apoptotic ratio (AR) was expressed by mean AR (± 
standard deviation). It was 0.18 ± 0.1 for the total sample, being 
0.14 ± 0.06 for the animals that underwent 4h of reperfusion and 
0.19 ± 0.08 for those after 24h of reperfusion (p<0.05) (Figure 5). 
In both 4h and 24h reperfusion groups, the highest 
AR values were found in the CTG, followed by SCG and SG. 
Differences among groups were non-significant in animals with 
4h of reperfusion, but statistical significance was seen when 
comparing groups of animals that underwent 24h of reperfusion 
(Figure 6).
In SG, no statistical significance was found comparing 
AR values of animals that underwent 4h to those after 24h of 
reperfusion (p = 0.4). However, animals after 24h of reperfusion 
had statistically significant higher AR values compared to those 
that underwent 4h of reperfusion (p = 0.04) in CTG and CSG.
The inter-reader reproducibility for the AR measurement 
showed a very strong correlation between readers, with intraclass-
correlation coefficient of 0.97 (95% confidence interval: 0.96, 
0.99). The Bland-Altman plots showed a mean difference of 
0.003±0.06 and 95% limits of agreement from -0.12 to 0.12 
(Figure 7).
FIGURE 5 - Box-and-whisker plot showing the distribution of the 
apoptotic ratio in accordance with the time of reperfusion for all animals: 
4h (n = 18) or 24h (n = 21). *p value refers to comparison between the 
averages of groups of 4h and 24h of reperfusion, using the Wilcoxon test.
FIGURE 6 - Distribution for apoptotic ratio among groups, according to 
the reperfusion time. SG – sham group; CTG – vehicle treated control 
group; SCG – sildenafil citrate group. In the graph, X refers to the value 
of standard deviation. *p value.
FIGURE 7 - Scatter plots and Bland-Altman plots for the inter-reader 
reproducibility of apoptotic ratio by caspase-3 expression (n=39).
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Discussion
To the best of our knowledge, this is the first study 
assessing the influence of SC in skeletal muscle IRI lesions. SC 
showed a protective effect for hindlimb skeletal muscle damage 
due to IRI. These benefitial effects were more pronounced at the 
late reperfusion (24h) time point, compared to early reperfusion 
(4h). Additionally, the assessment of apoptotic ratio based on 
the caspase-3 expression by immunohistochemistry staining had 
robust precision.
Despite improvements in operative techniques, acute 
ischemia of the lower limb remains a challenging clinical problem 
with significant morbidity and mortality. Its incidence may be as 
high as 13-17 cases per 100.000 people per year and mortality 
rates may reach 18% in some series12. Due to the high metabolic 
demand of skeletal muscle, irreversible damage may occur when 
perfusion occurs even after brief ischemic intervals7,13. In this 
regard, the soleus muscle is particularly sensitive to ischemia 
due to its metabolism14.  Surgical reperfusion is the established 
therapy early after the onset of ischemic conditions, but long-term 
ischemia increases additional tissue damage due to IRI. 
Quantitative evaluation of apoptosis by caspase-3 
expression using immunohistochemistry staining is well 
established5. We assessed the precision of the method and found 
a strong intra-class correlation, with mean difference between two 
independent readers close to null and narrow limits of agreement 
(Figure 4). This robust inter-reader reproducibility for the AR 
strengthens the reliability of our findings.
In our study, a six-hour ischemia ensured a significant 
injury to the soleus muscle, as showed by the lower AR found 
in SG when compared to the other groups (Figure 2). Evidence 
shows that ischemic morphological lesions are present minutes 
after reperfusion and increase progressively over time, due to 
an additional inflammatory response. In fact, cell death due 
to IRI is more evident after 4 hours of reperfusion, reaching 
the maximum peak at 24 hours14,15. In early reperfusion stages, 
most of the injury is associated with the acute release of free 
radicals. In late reperfusion, cell death factors are mostly related 
to IRI inflammatory pathways, with increasing importance of a 
neutrophil response.
SC is a PDE5 inhibitor and its mechanism of action 
involves increased tissue levels of cGMP, resulting in smooth muscle 
relaxation and increased vasodilation16. SC is effective for the 
treatment of erectile dysfunction and pulmonary hypertension17,18. 
Moreover, SC has protective effects over IRI in heart, kidney, 
liver, and brain19,20. However, the literature is focused on the use 
of SC before the onset of ischemia, acting in a pharmacological 
preconditioning. In the clinical setting, the onset of acute ischemia 
is usually unanticipated, which makes the delivery of a protective 
agent before the onset of ischemia impossible. We assessed the 
cytoprotective effect of SC administrated half an hour before the 
reperfusion, so that they would be present in the blood at the start 
of the reperfusion period. This nearly simulates the normal human 
condition when a patient is admitted to an emergency clinic and 
undergoes a revascularization procedure.
We assessed soleus muscle apoptosis in periods of early 
reperfusion (4h) and late reperfusion (24h). Animals that received 
SC had lower AR than those in the control group. Although the 
full mechanism involved was not explored, our results suggest 
that SC has a protective effect over IRI of skeletal muscle. In the 
early reperfusion phase, the mean difference on AR among groups 
did not show statistical significance. After 24h of reperfusion, 
AR values were significantly lower for SCG compared to CTG 
(Figure 3). These findings indicate that SC protects agains 
skeletal muscle damage, especially in injuries related to the late 
phase of reperfusion. On the other hand, the results found in a 
late reperfusion phase may be consequence of the SC action in 
reducing ROS in the early phase. 
Some points to be explored in future studies is the use 
of parenteral SC, an assessment of its effects when applied before 
ischemia as a preconditioning pharmacological, the effects of SC 
in remote organ damage after ischemia of skeletal muscle, as well 
as investigating the molecular mechanisms by which the SC has the 
cytoprotective effect in IRI in skeletal muscle. Subsequent studies 
could confirm these findings and translate the knowledge on the 
use of SC in IRI in the clinical area, making possible advances that 
bring therapeutic benefit in future medical practice.
Conclusion
In the model of six hours of ischemia in the rat hind limb, 
sildenafil citrate significantly reduced the apoptotic ratio in rat 
soleus muscle after 24 hours of reperfusion. 
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